MEASUREMENT OF CYCLOSPORINE-A BY A SPECIFIC RADIOIMMUNOASSAY WITH A MONOCLONAL-ANTIBODY AND I-125 TRACER

被引:15
作者
LEE, SC
BRUDZINSKI, AM
YASMINEH, JL
JOHANSON, NJ
FERBER, IA
MAAS, LK
WONG, PY
KEOWN, PA
ORF, JW
机构
[1] TORONTO GEN HOSP,TORONTO M5G 1L7,ONTARIO,CANADA
[2] BRITISH COLUMBIA TRANSPLANT SOC,VANCOUVER,BC,CANADA
关键词
CYCLOSPORINE-A; DRUG MONITORING; RADIOIMMUNOASSAY; TRANSPLANTATION; MONOCLONAL ANTIBODY;
D O I
10.1016/0009-9120(91)90168-E
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
We developed a sensitive radioimmunoassay (CYCLO-Trac(R) SP) that specifically measures cyclosporine A in serum, plasma and whole blood of transplant patients. The specific monoclonal antibody was from Sandoz and the tracer was an I-125 derivative of cyclosporine C. The assay is performed at room temperature for 1 h followed by a 20 min centrifugation. The sensitivities of the assays are 2.6 ng/mL and 8.7 ng/mL for the serum/plasma assay and the whole blood assay, respectively. Within-run and between-run CVs for both types of assays using cyclosporine concentrations of 80 and 58 ng/mL (serum) and 186 and 199 ng/mL (whole blood) were less than 5% and 9%, respectively. Averaged recovery of serum/plasma and whole blood assays at various levels ranged from 93% to 115%. Interferences by bilirubin, triglyceride, cholesterol, hemoglobin, OKT-3, azathioprine, methylprednisolone and 20 other drugs were insignificant. Multicenter proficiency studies showed an excellent correlation between the CYCLO-Trac(R) SP and the specific H-3-Sandimmune(R) assay from Sandoz: whole blood assay (r = 0.998) and serum assay (r = 0.997).
引用
收藏
页码:43 / 48
页数:6
相关论文
共 29 条
[1]  
ANNESLEY T, 1986, CLIN CHEM, V32, P1407
[2]  
BALL PE, 1988, CLIN CHEM, V34, P357
[3]   CYCLOSPORINE BLOOD-CONCENTRATIONS DETERMINED BY SPECIFIC VERSUS NONSPECIFIC ASSAY-METHODS [J].
BLYDEN, GT ;
FRANKLIN, C ;
CHO, SI ;
KAPLAN, MM ;
HIRSCH, CA ;
GREENBLATT, DJ .
JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 26 (05) :367-371
[4]   CYCLOSPORINE - EXPERIENCE WITH THERAPEUTIC MONITORING [J].
BOWERS, LD ;
CANAFAX, DM .
THERAPEUTIC DRUG MONITORING, 1984, 6 (02) :142-147
[5]  
CARRUTHERS SG, 1983, CLIN CHEM, V29, P180
[6]  
COPELAND KR, 1989, CLIN CHEM, V35, P1551
[7]  
Donatsch P, 1981, J Immunoassay, V2, P19, DOI 10.1080/01971528108062989
[8]   INVITRO IMMUNOSUPPRESSIVE PROPERTIES OF CYCLOSPORINE METABOLITES [J].
FREED, BM ;
ROSANO, TG ;
LEMPERT, N .
TRANSPLANTATION, 1987, 43 (01) :123-127
[9]  
Hawkins D., 1980, IDENTIFICATION OUTLI, P85
[10]  
JOHNSTON A, 1989, CLIN CHEM, V35, P1309